Pure Global
NCT03683641

Extracorporeal Shockwave Therapy in Insertional Achilles Tendinopathy

Mahidol University·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Insertional Achilles Tendinopathy
Drug/Device/Intervention
Extracorporeal Shock Wave Therapy
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Mahidol University
Timeline & enrollment
Phase
N/A
Start date
Jul 04, 2016
End date
Jul 31, 2018
Enrollment
30 participants
Primary outcome

Visual Analog Scale

Summary

There is still limited number of studies in the literature provides insufficient evidence to
 support the use of ESWT in the treatment of insertional Achilles tendinopathy and the
 contribution of a placebo effect to the shock waves was not assessed by previous study. So
 the investigators conducted a double-blinded randomized-controlled trial at the orthopedic
 out-patient clinic, Department of Orthopedics, Faculty of Medicine Ramathibodi Hospital
 between December 2016 and June 2018. Hypothesized that ESWT might be effective on insertional
 Achilles tendinopathy

ICD-10 classifications
Achilles tendinitisInjury of Achilles tendonShort Achilles tendon (acquired)Spontaneous rupture of unspecified tendonInjury of unspecified muscle and tendon at ankle and foot level
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03683641
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT03683641 through Pure Global AI's free database. This phase not specified trial is sponsored by Mahidol University and is currently Completed. The study focuses on Insertional Achilles Tendinopathy. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.